BioLargo, Inc.
BLGO
$0.22
$0.01537.47%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -181.71% | -39.09% | 55.25% | 66.79% | -65.99% |
| Total Depreciation and Amortization | 107.32% | -23.86% | -10.53% | -30.23% | 86.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -125.10% | -76.57% | -140.90% | 70.59% | 2.78% |
| Change in Net Operating Assets | -222.34% | -313.24% | -373.13% | 107.48% | 909.59% |
| Cash from Operations | -480.46% | -95,700.00% | -93.78% | 89.82% | 1,218.60% |
| Capital Expenditure | -- | 117.12% | 80.98% | -353.16% | -1,697.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 60.96% | 80.98% | -353.16% | -1,697.92% |
| Total Debt Issued | -- | 1,229.23% | -- | -- | -- |
| Total Debt Repaid | 20.00% | -103.64% | 66.67% | 40.00% | 92.31% |
| Issuance of Common Stock | -72.89% | -- | 232.47% | 21.60% | -19.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 5,628.57% | -- | -- | -- |
| Cash from Financing | -20.04% | 109.20% | 50.69% | -46.89% | -28.28% |
| Foreign Exchange rate Adjustments | -120.83% | 140.52% | 1,100.00% | -771.43% | 1,700.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -223.46% | -167.20% | -65.67% | 37.94% | -43.60% |